In This Article:
Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite surges for obesity drugmakers Eli Lilly and Novo Nordisk But the sector is off to a healthy start in 2025. Is the worst finally over for Big Pharma, biotechs, insurers, and medical device makers? CVS Health —which owns insurer Aetna and pharmacy-benefits manager Caremark, along with its massive drugstore franchise—is the second best-performing stock in the this year, surging nearly 30% as of Wednesday.